Top NYC, NY Biotech Companies (114)
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for Repligen are reaching out to prospective job applicants using fraudulent email addresses. All legitimate communications from Repligen will be sent from an individual with an email address ending in @repligen.com. If you have any concerns that a communication may be fraudulent and you would like to confirm whether it is, you may email legal@repligen.com and someone will respond. Repligen is a bioprocessing-focused life sciences company bringing over 40 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies. Repligen headquarters is in Waltham, Massachusetts and our manufacturing facilities are located around the world. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. Founded in 2022 by Population Health Partners and ARCH Venture Partners, Metsera has raised $290 million in financing from leading healthcare investors and is based in New York City.
Valo is a technology company built to transform the drug discovery and development process using human-centric data and AI-powered computation. Valo is fully integrating human-centric data across the entire drug development lifecycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing the cost, time, and failure rate. The company’s Opal Computational Platform™ consists of an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease.
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians
 copy.png)
Thesis is quickly reinventing the world of brain health and mental performance. We are the first company to personalize nootropics (brain supplements). Using the world’s most extensive nootropics data set, we recommend nutrients for our customers based on their unique neurochemistry. When it comes to energy, focus and motivation, our mission is to unlock possibilities. We are rapidly growing into industry leaders, and have helped tens of thousands of people overcome mental obstacles and start meeting their potential - one day at a time.
Apertura is a biotechnology company opening opportunities in gene therapy for treating debilitating diseases with limited options. We are pioneering next-generation AAV gene therapies by simultaneously engineering capsids, regulatory elements, and payloads to overcome current limitations in genetic medicine. Founded on technologies from the Broad Institute and Harvard University, and with support from Deerfield Management Company, we are located at the Cure in New York City.
Founded in Boston in 2007, ClearView Healthcare Partners is a diverse, inclusive, and innovative global strategy consulting firm serving the life science sector. The firm combines international industry knowledge and deep scientific expertise across a range of therapeutic areas with an extensive network of external stakeholders to deliver practical and actionable recommendations to our clients’ most complex challenges. The firm’s projects include cross-functional support at the corporate, franchise, and product levels for pharmaceutical, biotech, medical device, and diagnostics companies worldwide. We take pride in deploying high caliber consulting teams from our Boston, New York, San Francisco, London and Zurich offices that can provide the best support available on issues that require strategic capabilities and deep content expertise within life sciences. ClearView was ranked #13 overall and #1 boutique in the 2020 Vault Consulting 50. Specific rankings include Top 5 for Innovation, Formal and Informal Training, and Internal Mobility and Promotion Policies. ClearView was also ranked Top 10 for Firm Leadership, Compensation, and Firm Culture. CLEARVIEW HEALTHCARE PARTNERS® is a registered trademark of ClearView Healthcare Partners, LLC in the United States, the UK, Switzerland, the European Union, and various other countries. All Rights Reserved.
Tradewind Markets is a financial technology company that enables physical and alternative assets to be traded, settled, and mobilized with increased confidence, security, transparency, and cost efficiency. Tradewind created a digital precious metals market that uses both blockchain technology and electronic exchange technology to streamline custody, trade execution, settlement and the maintenance of supply chain information. The Tradewind platform has been adopted by leading institutions in the precious metals market, including the Royal Canadian Mint and Asahi Refining. Investors in the business include IEX Group, Sprott Inc., Goldcorp Inc., Agnico Eagle Mines Ltd., IAMGOLD Corp, and Wheaton Precious Metals Corp.
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
Kintara Therapeutics is a developer of novel cancer therapies for patients with unmet medical needs.
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care. More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test is a Life, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to ensure test results are fast, accurate, and reliable. Ortho's customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs. From launching the first product to determine Rh+ or Rh- blood type, developing the world’s first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology and marketing the first U.S. Food and Drug Administration-authorized high-volume antibody and antigen tests for COVID-19, Ortho has been a pioneering leader in the IVD space for over 80 years. The company is powered by Ortho Care, an award-winning, holistic service and support program that ensures best-in-class technical, field and remote service and inventory support to laboratories in more than 130 countries and territories around the globe.
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution. TandemAI has built its networked platform from the ground up in the U.S. and China to increase the speed of drug discovery and deliver cost-effective opportunities to its partners and to the global scientific community.
Aethon takes a novel approach to fighting cancer, creating custom antibody therapeutics that unite immunotherapy and targeted therapy.
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
Conexus Solutions, Inc. is a solutions provider of Outsourced Sales Operations specializing in CRM implementation, data management, reporting and analytics. Our core expertise lies in providing these services to the Biotech, Pharmaceutical and Life Sciences industries with a focus on small to medium sized companies. Conexus is a "Veeva Services Partner" for multi channel CRM implementation and support, Certified MyInsights, Open Data Partner and Veeva Vault. Additionally, we have developed and implemented a variety of proprietary CRM connected solutions based on our domain expertise and industry needs. For more information please contact us at info@cnxsi.com or visit our website at www.cnxsi.com.
AdMed is an integrated agency that designs and delivers modern training tools for pharmaceutical, biotech, diagnostic and medical products, with one goal: to ensure that healthcare professionals, sales teams, employees and consumers understand what they need to know regarding the science behind their products. This is tomorrow’s teaching like you’ve imagined it – with proven results. Our interactive and immersive approach features Flipped Classroom modern learning, enhanced visual micro lectures, and other forward-leaning learning techniques. AdMed’s talented team of content developers, instructional technology experts, programmers, and animators are dedicated to understanding your objectives and achieving your goals by using state-of-the-art technologies. Our medical writing staff consists of MD, PhD, and PharmD professionals with extensive industry experience. Mission: Breaking down the walls of complex science and opening it up to all.
